Thabor Therapeutics appoints Jérémie Mariau as CEO
Barbara IoT raises €2.5M in funding from Caixa Capital Risc and Iberdrola
BioWin spearheads ‘Talent Now’, a unique initiative to tackle recruitment shortages and challenges in the healthtech industry
Biomunex unveils MAIT cell redirection approach for lead immune-oncology program at PEGS Boston Conference
AdBio partners welcomes Inserm Transfert as investor in second fund – AFB Fund II
Biomunex appoints Dr. Simon Plyte, PhD, as Chief Scientific Officer to boost clinical and business development
Ribonexus receives €2M in deep tech financing from Bpifrance
Seekyo adds diagnostics and theranostics capabilities to its lead compound SKY01 that targets solid tumors
